ALX Oncology to Present ALX148 Clinical Data at the ESMO 23rd World Congress on Gastrointestinal Cancer

NEXT STORY
Brandywine Realty Trust Announces First Quarter Results And Narrows 2021 Guidance
PREV STORY
PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Peregrine Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial Evaluating Bavituximab Treatment Combination in Patients with Newly Diagnosed Glioblastoma

TUSTIN, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a ...

author_avatar
NASDAQ Market News

Research Finds U.S. Cardiogenic Shock Patients Have High Hospital Inpatient Mortality and Long Length of Stay – Adding to Previously Reported Need for New Pharmacologic Innovation

author_avatar
NASDAQ Market News

Northeast Business Group on Health Releases Employer Guide to Genomic Medicine

NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Northeast Business Group on Health (NEBGH) ...

author_avatar
NASDAQ Market News